The baseline recurrence risk of patients with intermediate-risk cervical cancer.

Yoneoka, Yutaka; Kato, Mayumi Kobayashi; Tanase, Yasuhito; Uno, Masaya; Ishikawa, Mitsuya; Murakami, Takashi; Kato, Tomoyasu

Yoneoka, Yutaka; Kato, Mayumi Kobayashi; Tanase, Yasuhito; Uno, Masaya; Ishikawa, Mitsuya; Murakami, Takashi; Kato, Tomoyasu.

Afiliação

Yoneoka Y; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Kato MK; Department of Obstetrics and Gynecology, Shiga University of Medical Science, Shiga, Japan.
Tanase Y; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Uno M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Murakami T; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Kato T; Department of Obstetrics and Gynecology, Shiga University of Medical Science, Shiga, Japan.

Obstet Gynecol Sci ; 64(2): 226-233, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33752280

Palavras-chave

Adenocarcinoma; Carcinoma; Recurrence; Squamous cells; Uterine cervical neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google